Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00954720 · ClinicalTrials.gov registry record
Observational Study of Iron Overload in Stem Cell Transplantation
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 45
- Enrollment target
NCT00954720 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 45 participants.
The verdict
NCT00954720 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Recent retrospective studies have suggested that iron overload is a clinically important problem in patients undergoing ablative stem cell transplantation. However, these studies relied on serum ferritin as a surrogate of iron overload, which limits the conclusions that can be drawn from such analyses. Therefore, the investigators are conducting a prospective study to more rigorously examine the prevalence, mechanisms, and consequences of iron overload in this patient population.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00954720
The ClinicalTrials.gov registry entry for NCT00954720 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT00954720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00954720 about?
NCT00954720 is a clinical study titled "Observational Study of Iron Overload in Stem Cell Transplantation". Recent retrospective studies have suggested that iron overload is a clinically important problem in patients undergoing ablative stem cell transplantation. However, these studies relied on serum ferritin as a surrogate of iron overload, which limits the conclusions that can be drawn from such analys...
What is the current status of trial NCT00954720?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-03. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00954720?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT00954720?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.